Abstract:Abstract The pancreas is highly innervated with sensory, autonomic and enteric neurons, and recent studies have highlighted the crosstalk between neurons and pancreatic cells and their potential role in driving tumorigenesis and promoting metastasis. Published data has shown that ablation of sensory neurons in models of pancreatic ductal adenocarcinoma (PDAC) resulted in delayed tumor initiation and progression. In addition, perineural invasion (PNI), the invasion of tumor cells along the nerve, is a pathological characteristic frequently observed in PDAC. PNI has been detected in early stages of pancreatic cancer and associated with a poor outcome. We hypothesized that PDAC tumor cells express neuronal genes which may be playing a role in enabling tumor-nerve interactions and promoting PDAC tumorigenesis. Here we used pooled sgRNA CRISPR screening to probe a library of 5000 sgRNAs targeting 800 neuronal genes. We selected three established (MiaPaca-2, Panc-1 and BxPC3) and two patient derived human PDAC cell lines (PAXF1657 and PAXF1997) and performed in vitro and in vivo CRISPR screens. sgRNAs targeting the CYFIP1 gene were negatively selected across multiple cell line models in vitro and in vivo. Cytoplasmic FMR1 interacting protein 1 (CYFIP1) is a protein that has been described to regulate actin polymerization and protein translation through two distinct protein complexes. CYFIP1 is a member of the heteropentameric WAVE regulatory complex (WRC) which includes CYFIP1, WAVE, NAP1, ABI, and HSPC300. Rac1 binding to CYFIP1 results in activation of WRC, allowing WAVE to interact with Apr2/3 and enabling actin polymerization. In addition, CYFIP1 can interact with fragile X mental retardation protein (FMRP) and eIF4E, acting as a translation repressor. CYFIP1 is highly expressed at excitatory synapses of neurons and is required for proper dendritic spine morphology. CYFIP1 has been linked to neurological and neuropsychiatric conditions such as autism, epilepsy and schizophrenia due to its location in a chromosomal region (15q11.2) with frequent copy number variations. In order to validate the pooled CRISPR screen results we individually knocked out CYFIP1 in PDAC cancer cell lines. We were able to show that knockout of CYFIP1 reduced proliferation of PDAC cells in vitro and dramatically reduced tumor growth in vivo. Additionally, knockout of CYFIP1 resulted in reduced protein levels of WRC members WAVE1 and NCKAP1, suggesting destabilization of the complex. The mechanism by which CYFIP1 promotes tumor growth has yet to be elucidated, but our data shows that CYFIP1 is playing a critical role in PDAC tumorigenesis and is a potential therapeutic target. Citation Format: Kiley Couto, Matthew Strickland, Tiffany Liao, Mortada Najem, Aaron Fulgham, Ameya Apte, Pearl Huang, Jonathan Hurov, Alexandra Lantermann. The autism and schizophrenia-associated CYFIP1 protein is required for pancreatic tumor growth and presents a potential therapeutic target [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics; 2019 Oct 26-30; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2019;18(12 Suppl):Abstract nr LB-C05. doi:10.1158/1535-7163.TARG-19-LB-C05

Cyfip1 Is A Potential Tumor Suppressor In Human Diffuse Large B-Cell Lymphoma

Tumor-suppressive Functions of Leucine Zipper Transcription Factor-Like 1.

The Prognostic and Clinicopathological Significance of PD-L1 Expression in Patients with Diffuse Large B-cell Lymphoma: a Meta-Analysis

Dysregulated CXCR4 Expression Promotes Lymphoma Cell Survival and Independently Predicts Disease Progression in Germinal Center B-cell-like Diffuse Large B-cell Lymphoma.

[Prognostic Significance of Proteins Expression by Immunohistochemical Method in Diffuse Large B Cell Lymphoma].

ICT1 Predicts a Poor Survival and Correlated with Cell Proliferation in Diffuse Large B-cell Lymphoma.

KIF23 is a potential biomarker of diffuse large B cell lymphoma Analysis based on bioinformatics and immunohistochemistry

Interfering B cell receptor signaling via SHP-1/p-Lyn axis shows therapeutic potential in diffuse large B-cell lymphoma

Clinical Significance of Down-Regulated Cylindromatosis Gene in Chronic Lymphocytic Leukemia

PD-L1 Over-Expression is Driven by B-cell Receptor Signaling in Diffuse Large B-cell Lymphoma

Yin Yang 1 expression predicts a favourable survival in diffuse large B-cell lymphoma

Downregulation of CYLD promotes IFN-γ mediated PD-L1 expression in thymic epithelial tumors

Abstract LB-C05: The autism and schizophrenia-associated CYFIP1 protein is required for pancreatic tumor growth and presents a potential therapeutic target

MYC Protein Dysregulation is Driven by BCR-PI3K Signaling in Diffuse Large B-cell Lymphoma.

TCP1 expression alters the ferroptosis sensitivity of diffuse large B-cell lymphoma subtypes by stabilising ACSL4 and influences patient prognosis

Cytl1 is a Key Target for Chemoradiotherapy Resistance in Locally Advanced Cervical Cancer: Based on Bioinformatics Analysis

PB2108: PREVALENCE AND CLINICAL IMPLICATIONS OF CYCLIN D1 POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA IN CHINA

Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma

Significance of chromobox protein (CBX) expression in diffuse LBCL

High PPP4C expression predicts poor prognosis in diffuse large B-cell lymphoma

Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma